Inhibition	O
of	O
protein	B-protein
phosphatase	I-protein
2A	I-protein
induces	O
serine/threonine	O
phosphorylation	O
,	O
subcellular	O
redistribution	O
,	O
and	O
functional	O
inhibition	O
of	O
STAT3	B-protein
.	O

Signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	O
STATs	B-protein
)	O
are	O
rapidly	O
phosphorylated	O
on	O
tyrosine	O
residues	O
in	O
response	O
to	O
cytokine	B-protein
and	O
growth	B-protein
factor	I-protein
stimulation	O
of	O
cell	B-protein
surface	I-protein
receptors	I-protein
.	O

STATs	B-protein
hereafter	O
are	O
translocated	O
to	O
the	O
nucleus	O
where	O
they	O
act	O
as	O
transcription	B-protein
factors	I-protein
.	O

Recent	O
reports	O
suggest	O
that	O
serine	O
phosphorylation	O
of	O
STATs	B-protein
also	O
is	O
involved	O
in	O
the	O
regulation	O
of	O
STAT	B-protein
-mediated	O
gene	O
transcription	O
.	O

Here	O
,	O
we	O
studied	O
the	O
role	O
of	O
serine/threonine	B-protein
phosphatases	I-protein
in	O
STAT3	B-protein
signaling	O
in	O
human	B-cell_line
antigen-specific	I-cell_line
CD4	I-cell_line
(	I-cell_line
+	I-cell_line
)	I-cell_line
T	I-cell_line
cell	I-cell_line
lines	I-cell_line
and	O
cutaneous	B-cell_line
T	I-cell_line
cell	I-cell_line
lymphoma	I-cell_line
lines	I-cell_line
,	O
expressing	O
a	O
constitutively	O
activated	O
STAT3	B-protein
.	O

We	O
show	O
that	O
an	O
inhibitor	O
of	O
protein	B-protein
phosphatases	I-protein
(	O
PPs	B-protein
)	O
PP1/PP2A	B-protein
,	O
calyculin	B-protein
A	I-protein
,	O
induces	O
(	O
i	O
)	O
phosphorylation	O
of	O
STAT3	B-protein
on	O
serine	O
and	O
threonine	O
residues	O
,	O
(	O
ii	O
)	O
inhibition	O
of	O
STAT3	B-protein
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
,	O
and	O
(	O
iii	O
)	O
relocation	O
of	O
STAT3	B-protein
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O

Similar	O
results	O
were	O
obtained	O
with	O
other	O
PP2A	O
inhibitors	O
(	O
okadaic	O
acid	O
,	O
endothall	O
thioanhydride	O
)	O
but	O
not	O
with	O
inhibitors	O
of	O
PP1	B-protein
(	O
tautomycin	O
)	O
or	O
PP2B	B-protein
(	O
cyclosporine	O
A	O
)	O
.	O

Pretreatment	O
with	O
the	O
broad	O
serine/threonine	O
kinase	O
inhibitor	O
staurosporine	O
partly	O
blocked	O
the	O
calyculin	B-protein
A	I-protein
-induced	O
STAT3	B-protein
phosphorylation	O
,	O
whereas	O
inhibitors	O
of	O
serine/threonine	B-protein
kinases	I-protein
,	O
such	O
as	O
mitogen-activated	B-protein
protein	I-protein
kinase-1	I-protein
extracellular-regulated	I-protein
kinase-kinase	I-protein
,	O
mitogen-activated	B-protein
protein	I-protein
p38	I-protein
kinase	I-protein
,	O
and	O
phosphatidylinositol	B-protein
3-kinase	I-protein
,	O
did	O
not	O
.	O

In	O
conclusion	O
,	O
we	O
provide	O
evidence	O
that	O
PP2A	B-protein
plays	O
a	O
crucial	O
role	O
in	O
the	O
regulation	O
of	O
STAT3	B-protein
phosphorylation	O
and	O
subcellular	O
distribution	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Moreover	O
,	O
our	O
findings	O
suggest	O
that	O
the	O
level	O
of	O
STAT3	B-protein
phosphorylation	O
is	O
balanced	O
between	O
a	O
staurosporine-sensitive	B-protein
kinase	I-protein
(	O
s	O
)	O
and	O
PP2A	B-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

96	NULL
,	NULL
pp	NULL
.	NULL

10620-10625	NULL
,	NULL
September	NULL
1999	NULL
Biochemistry	NULL
Inhibition	NULL
of	NULL
protein	NULL
phosphatase	NULL
2A	NULL
induces	NULL
serine/threonine	NULL
phosphorylation	NULL
,	NULL
subcellular	NULL
redistribution	NULL
,	NULL
and	NULL
functional	NULL
inhibition	NULL
of	NULL
STAT3	NULL
ANDERS	NULL
WoOETMANN®*	NULL
,	NULL
METTE	NULL
NIELSEN®*	NULL
,	NULL
S	NULL
@	NULL
REN	NULL
T.	NULL
CHRISTENSENT	NULL
,	NULL
JOHANNES	NULL
BROCKDORFF*	NULL
,	NULL
KELD	NULL
KaLTOFT	NULL
#	NULL
,	NULL
ANNE-	NULL
MARIE	NULL
ENGEL§	NULL
,	NULL
S	NULL
@	NULL
REN	NULL
Skov*	NULL
,	NULL
CHRISTINE	NULL
BRENDER*	NULL
,	NULL
CARSTEN	NULL
GEISLER*	NULL
,	NULL
ARNE	NULL
SvEIGAARD1	NULL
,	NULL
JoRGEN	NULL
VagNn	NULL
LEIcKk	NULL
?	NULL

,	NULL
anD	NULL
NiELs	NULL
Opum*	NULL
!	NULL

Institutes	NULL
of	NULL
*Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
and	NULL
*Medical	NULL
Biochemistry	NULL
and	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
DK2200	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
;	NULL
Department	NULL
of	NULL
Clinical	NULL
Immunology	NULL
,	NULL
The	NULL
National	NULL
University	NULL
Hospital	NULL
,	NULL
DK2200	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
;	NULL
§The	NULL
Bartholin	NULL
Institute	NULL
,	NULL
Kommunehospitalet	NULL
,	NULL
DK1399	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
;	NULL
and	NULL
*Institute	NULL
for	NULL
Human	NULL
Genetics	NULL
,	NULL
Aarhus	NULL
University	NULL
,	NULL
DK8000	NULL
Aarhus	NULL
,	NULL
Denmark	NULL
Communicated	NULL
by	NULL
Hans	NULL
H.	NULL
Ussing	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
,	NULL
May	NULL
12	NULL
,	NULL
1999	NULL
(	NULL
received	NULL
for	NULL
review	NULL
February	NULL
25	NULL
,	NULL
1999	NULL
)	NULL
ABSTRACT	NULL
Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STATs	NULL
)	NULL
are	NULL
rapidly	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
stimulation	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

STAT	NULL
's	NULL
hereafter	NULL
are	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
act	NULL
as	NULL
transcription	NULL
factors	NULL
.	NULL

Recent	NULL
reports	NULL
suggest	NULL
that	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
's	NULL
also	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT-mediated	NULL
gene	NULL
transcrip-tion	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
serine/threonine	NULL
phosphatases	NULL
in	NULL
STAT3	NULL
signaling	NULL
in	NULL
human	NULL
antigen-specific	NULL
CD4+*	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
cutaneous	NULL
T	NULL
cell	NULL
lymphoma	NULL
lines	NULL
,	NULL
expressing	NULL
a	NULL
constitutively	NULL
activated	NULL
STAT3	NULL
.	NULL

We	NULL
show	NULL
that	NULL
an	NULL
inhibitor	NULL
of	NULL
protein	NULL
phosphatases	NULL
(	NULL
PPs	NULL
)	NULL
PP1/PP2A	NULL
,	NULL
calyculin	NULL
A	NULL
,	NULL
induces	NULL
(	NULL
?	NULL
)	NULL

phosphorylation	NULL
of	NULL
STAT3	NULL
on	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
,	NULL
(	NULL
i	NULL
?	NULL
)	NULL

inhibition	NULL
of	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
(	NULL
i	NULL
?	NULL
)	NULL

relocation	NULL
of	NULL
STAT3	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
other	NULL
PP2A	NULL
inhibitors	NULL
(	NULL
okadaic	NULL
acid	NULL
,	NULL
endothall	NULL
thioanhydride	NULL
)	NULL
but	NULL
not	NULL
with	NULL
inhibitors	NULL
of	NULL
PPI	NULL
(	NULL
tautomycin	NULL
)	NULL
or	NULL
PP2B	NULL
(	NULL
cyclo-sporine	NULL
A	NULL
)	NULL
.	NULL

Pretreatment	NULL
with	NULL
the	NULL
broad	NULL
serine/threonine	NULL
kinase	NULL
inhibitor	NULL
staurosporine	NULL
partly	NULL
blocked	NULL
the	NULL
calyculin	NULL
A-induced	NULL
STAT3	NULL
phosphorylation	NULL
,	NULL
whereas	NULL
inhibitors	NULL
of	NULL
serine/threonine	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
mitogen-activated	NULL
protein	NULL
kinase-1	NULL
extracellular-regulated	NULL
kinase-kinase	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
p38	NULL
kinase	NULL
,	NULL
and	NULL
phosphatidylinositol	NULL
3-ki-nase	NULL
,	NULL
did	NULL
not	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
PP2A	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
and	NULL
subcellular	NULL
distribution	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
level	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
is	NULL
balanced	NULL
between	NULL
a	NULL
staurosporine-sensitive	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
and	NULL
PP2A	NULL
.	NULL

STAT	NULL
's	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
are	NULL
latent	NULL
cytoplasmic	NULL
transcription	NULL
factors	NULL
that	NULL
upon	NULL
activation	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
activate	NULL
target	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
seven	NULL
STATs	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
all	NULL
of	NULL
which	NULL
have	NULL
an	NULL
Sre	NULL
homology	NULL
2	NULL
domain	NULL
near	NULL
their	NULL
carboxyl	NULL
terminus	NULL
and	NULL
a	NULL
tyrosine	NULL
residue	NULL
near	NULL
position	NULL
700	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Y¥705	NULL
in	NULL
STAT3	NULL
)	NULL
.	NULL

Upon	NULL
ligation	NULL
,	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
receptor-associated	NULL
Janus	NULL
kinases	NULL
(	NULL
JAKs	NULL
)	NULL
become	NULL
activated	NULL
,	NULL
possibly	NULL
by	NULL
transphosphorylation	NULL
and/or	NULL
autophos-phorylation	NULL
.	NULL

Once	NULL
activated	NULL
,	NULL
JAKs	NULL
phosphorylate	NULL
the	NULL
receptor	NULL
on	NULL
key	NULL
tyrosine	NULL
residues	NULL
,	NULL
which	NULL
leads	NULL
to	NULL
recruitment	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
are	NULL
tyrosine-phosphorylated	NULL
by	NULL
JAKs	NULL
.	NULL

Phosphorylated	NULL
STAT	NULL
proteins	NULL
homodimerize	NULL
or	NULL
het-erodimerize	NULL
through	NULL
reciprocal	NULL
Sre	NULL
homology	NULL
2-phospho-tyrosine	NULL
interactions	NULL
and	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

10620	NULL
bind	NULL
specific	NULL
DNA	NULL
elements	NULL
and	NULL
regulate	NULL
transcriptional	NULL
activity	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

STATs	NULL
also	NULL
are	NULL
serine-phosphorylated	NULL
in	NULL
response	NULL
to	NULL
liga-tion	NULL
of	NULL
many	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
receptors	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
major	NULL
site	NULL
for	NULL
serine	NULL
phosphorylation	NULL
in	NULL
STAT1	NULL
and	NULL
STAT3	NULL
is	NULL
residue	NULL
727	NULL
(	NULL
5	NULL
)	NULL
,	NULL
allthough	NULL
additional	NULL
serine	NULL
phosphorylation	NULL
sites	NULL
have	NULL
been	NULL
proposed	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
modulate	NULL
the	NULL
DNA	NULL
binding	NULL
and/or	NULL
transcriptional	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and/or	NULL
transcriptional	NULL
activity	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
serine	NULL
phosphorylation	NULL
also	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
whereas	NULL
other	NULL
findings	NULL
indicate	NULL
that	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
tyrosine	NULL
phosphorylation	NULL
or	NULL
DNA	NULL
binding	NULL
(	NULL
7	NULL
,	NULL
12-14	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
net	NULL
effect	NULL
of	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
depends	NULL
on	NULL
the	NULL
type	NULL
of	NULL
extracellular	NULL
stimulus	NULL
,	NULL
the	NULL
cell	NULL
type	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
status	NULL
of	NULL
the	NULL
cell	NULL
in	NULL
question	NULL
.	NULL

In	NULL
several	NULL
STAT	NULL
proteins	NULL
(	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
)	NULL
the	NULL
serine	NULL
residue	NULL
727	NULL
is	NULL
located	NULL
within	NULL
a	NULL
known	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
/extracellular-regulated	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
consensus	NULL
phosphorylation	NULL
site	NULL
(	NULL
pro-x-ser/thr-pro	NULL
)	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
MAPK/ERKs	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
serine-727	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
several	NULL
cell	NULL
systems	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
findings	NULL
indicate	NULL
that	NULL
non-ERK/MAPKs	NULL
also	NULL
are	NULL
involved	NULL
in	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STATs	NULL
might	NULL
be	NULL
controlled	NULL
by	NULL
several	NULL
kinases	NULL
,	NULL
including	NULL
known	NULL
and	NULL
as-yet-unidentified	NULL
serine	NULL
kinases	NULL
.	NULL

Four	NULL
major	NULL
classes	NULL
of	NULL
serine/threonine-specific	NULL
protein	NULL
phosphatases	NULL
(	NULL
PPs	NULL
)	NULL
have	NULL
been	NULL
described	NULL
.	NULL

These	NULL
include	NULL
PP1	NULL
,	NULL
PP2A	NULL
,	NULL
PP2B	NULL
(	NULL
calcineurin	NULL
)	NULL
,	NULL
and	NULL
PP2C	NULL
,	NULL
with	NULL
PP2B	NULL
and	NULL
PP2C	NULL
being	NULL
Ca**	NULL
dependent	NULL
,	NULL
whereas	NULL
PP1	NULL
and	NULL
PP2A	NULL
are	NULL
not	NULL
.	NULL

PP1	NULL
and	NULL
PP2A	NULL
are	NULL
widely	NULL
distributed	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
mammalian	NULL
cells	NULL
and	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
signaling	NULL
pathways	NULL
,	NULL
controlling	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
participating	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
protein	NULL
kinases	NULL
and/or	NULL
PPs	NULL
,	NULL
which	NULL
themselves	NULL
are	NULL
key	NULL
regulators	NULL
of	NULL
cell	NULL
function	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

20	NULL
)	NULL
.	NULL

Circumstantial	NULL
evidence	NULL
suggests	NULL
that	NULL
PP2A	NULL
might	NULL
be	NULL
Abbreviations	NULL
:	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
PP	NULL
,	NULL
protein	NULL
phosphatase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular-regulated	NULL
kinase	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
MEK	NULL
,	NULL
MAPK/ERK	NULL
kinase	NULL
;	NULL
hSIE	NULL
,	NULL
high-affinity	NULL
sis-inducible	NULL
element	NULL
;	NULL
pIRE	NULL
,	NULL
palindromic	NULL
IFN	NULL
regulatory	NULL
element	NULL
;	NULL
OA	NULL
,	NULL
okadaic	NULL
acid	NULL
;	NULL
CA	NULL
,	NULL
calyculin	NULL
A	NULL
;	NULL
ETA	NULL
,	NULL
endothall	NULL
thioanhydride	NULL
;	NULL
TAU	NULL
,	NULL
tautomycin	NULL
;	NULL
CyA	NULL
,	NULL
cyclosporine	NULL
A	NULL
;	NULL
ICAM-1	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
GAS	NULL
,	NULL
gamma	NULL
IFN	NULL
activation	NULL
site	NULL
.	NULL

!	NULL

'To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Institute	NULL
of	NULL
Medical	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Panum	NULL
22.5.34	NULL
,	NULL
University	NULL
of	NULL
Copenhagen	NULL
,	NULL
Blegdamsvej	NULL
3¢	NULL
,	NULL
DK2200	NULL
Copenhagen	NULL
N	NULL
,	NULL
Denmark	NULL
.	NULL

E-mail	NULL
:	NULL
N.Odum	NULL
@	NULL
sb.immi.ku.dk	NULL
.	NULL

Biochemistry	NULL
:	NULL
Woetmann	NULL
et	NULL
al	NULL
.	NULL

directly	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT	NULL
signaling	NULL
.	NULL

Thus	NULL
,	NULL
purified	NULL
PP2A	NULL
dephosphorylates	NULL
STAT3	NULL
on	NULL
serine	NULL
residues	NULL
in	NULL
vitro	NULL
(	NULL
9	NULL
)	NULL
and	NULL
inhibits	NULL
the	NULL
formation	NULL
of	NULL
serine-dependent	NULL
STAT1	NULL
/IFN-y	NULL
activation	NULL
factor-DNA	NULL
complexes	NULL
in	NULL
vitro	NULL
(	NULL
8	NULL
)	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
PP2A	NULL
is	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
PP	NULL
inhibitors	NULL
on	NULL
the	NULL
function	NULL
and	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
cytokine-sensitive	NULL
,	NULL
human	NULL
CD4*	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
cutaneous	NULL
T	NULL
cell	NULL
lymphoma	NULL
lines	NULL
,	NULL
which	NULL
express	NULL
constitutively	NULL
tyrosine-phosphorylated	NULL
and	NULL
activated	NULL
STAT3	NULL
proteins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

Antigen-specific	NULL
human	NULL
CD4*	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
and	NULL
have	NULL
been	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Cutaneous	NULL
tumor	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
from	NULL
skin	NULL
biopsies	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
mycosis	NULL
fungoides	NULL
and	NULL
have	NULL
been	NULL
described	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
used	NULL
two	NULL
different	NULL
cell	NULL
lines	NULL
:	NULL
one	NULL
early	NULL
culture	NULL
(	NULL
My-la	NULL
3675	NULL
)	NULL
that	NULL
depends	NULL
on	NULL
the	NULL
cytokine	NULL
IL-2	NULL
and	NULL
one	NULL
long-term	NULL
culture	NULL
(	NULL
My-la	NULL
2059	NULL
)	NULL
that	NULL
grows	NULL
independently	NULL
of	NULL
cytokines	NULL
.	NULL

Antibodies	NULL
and	NULL
Other	NULL
Reagents	NULL
.	NULL

Antibodies	NULL
against	NULL
human	NULL
PP2A	NULL
(	NULL
P47720	NULL
)	NULL
,	NULL
STAT3	NULL
(	NULL
$	NULL
21320	NULL
)	NULL
,	NULL
and	NULL
STATS	NULL
(	NULL
$	NULL
21520	NULL
)	NULL
were	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
human	NULL
STAT3	NULL
(	NULL
K-15	NULL
,	NULL
#	NULL
sc-483	NULL
)	NULL
and	NULL
ERK	NULL
2	NULL
(	NULL
K-23	NULL
,	NULL
#	NULL
sc-153	NULL
)	NULL
were	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Antibodies	NULL
against	NULL
human	NULL
STAT3	NULL
(	NULL
#	NULL
9132	NULL
)	NULL
,	NULL
STAT3	NULL
phospho-tyrosine	NULL
705	NULL
(	NULL
#	NULL
9131L	NULL
)	NULL
,	NULL
STAT3	NULL
phospho-serine-727	NULL
(	NULL
#	NULL
9134L	NULL
)	NULL
,	NULL
and	NULL
phos-pho-thr202/tyr204	NULL
p42/44	NULL
MAPK	NULL
(	NULL
#	NULL
9106	NULL
)	NULL
were	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

FITC-	NULL
and	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibodies	NULL
against	NULL
mouse	NULL
Ig	NULL
(	NULL
#	NULL
P0260	NULL
)	NULL
and	NULL
rabbit	NULL
Ig	NULL
(	NULL
#	NULL
P0217	NULL
)	NULL
were	NULL
from	NULL
Dako	NULL
.	NULL

Calyculin	NULL
A	NULL
(	NULL
CA	NULL
)	NULL
,	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
endothall	NULL
thioanhydride	NULL
(	NULL
ETA	NULL
)	NULL
,	NULL
tautomy-cin	NULL
(	NULL
TAU	NULL
)	NULL
,	NULL
and	NULL
staurosporine	NULL
were	NULL
purchased	NULL
from	NULL
Alexsis	NULL
(	NULL
Laufel-Fingen	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Cyclosporine	NULL
A	NULL
(	NULL
CyA	NULL
)	NULL
was	NULL
from	NULL
Sandoz	NULL
Pharmaceutical	NULL
,	NULL
MAPK/ERK	NULL
kinase	NULL
(	NULL
MEK	NULL
)	NULL
inhibitor	NULL
(	NULL
PD98059	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
and	NULL
H7	NULL
(	NULL
1-	NULL
(	NULL
5-isoquinolinesulfonyl	NULL
)	NULL
-2-methylpiperazine	NULL
dihydrochlo-ride	NULL
)	NULL
was	NULL
from	NULL
Biomol	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Oligonucle-otides	NULL
used	NULL
were	NULL
:	NULL
IL-2Ra	NULL
«	NULL
gamma	NULL
IFN	NULL
activation	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
d	NULL
(	NULL
5'-TTTCTTCTAGGAAGTACC-3	NULL
'	NULL
)	NULL
,	NULL
IL-2Ra	NULL
GASp	NULL
(	NULL
5'-AC-ATTTCTGATAATAGAATT-3	NULL
'	NULL
)	NULL
(	NULL
24	NULL
)	NULL
,	NULL
pIRE	NULL
(	NULL
palindromic	NULL
IFN	NULL
regulatory	NULL
element	NULL
)	NULL
(	NULL
5'-AGCTTAGGTTTCCGGGAA-AGCAC-3	NULL
'	NULL
)	NULL
(	NULL
25	NULL
)	NULL
,	NULL
and	NULL
hSIE	NULL
(	NULL
high-affinity	NULL
sis-inducible	NULL
element	NULL
)	NULL
(	NULL
5'-GTCGACATTTCCCGTAAATCGTCGA-3	NULL
'	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Protein	NULL
Extraction	NULL
,	NULL
Immunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
Blotting	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
or	NULL
without	NULL
inhibitors	NULL
for	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
(	NULL
3	NULL
x	NULL
10°	NULL
cells/experiment	NULL
for	NULL
whole-cell	NULL
lysates	NULL
and	NULL
20	NULL
x	NULL
10°	NULL
for	NULL
immunoprecipitation	NULL
)	NULL
were	NULL
rapidly	NULL
pelleted	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
lysing	NULL
the	NULL
cells	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
[	NULL
1	NULL
%	NULL
NP-40/20	NULL
mM	NULL
Tris	NULL
:	NULL
HCI	NULL
,	NULL
pH	NULL
8.0/137	NULL
mM	NULL
NaCl/10	NULL
%	NULL
glycerol	NULL
with	NULL
the	NULL
following	NULL
inhibitors	NULL
:	NULL
1	NULL
mM	NULL
PMSF	NULL
(	NULL
in	NULL
DMSO	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO4	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ul/ml	NULL
indoleacetic	NULL
acid	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
]	NULL
.	NULL

Preparation	NULL
of	NULL
cytoplasmic/nuclear	NULL
extracts	NULL
,	NULL
immunoblotting	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
oligonucleotide	NULL
purification	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
(	NULL
22	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
evaluated	NULL
by	NULL
using	NULL
enhanced	NULL
chemiluminescence	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
manual	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
)	NULL
.	NULL

+P	NULL
Radiolabeling	NULL
of	NULL
Cells	NULL
and	NULL
Purification	NULL
of	NULL
P-Labeled	NULL
STAT3	NULL
.	NULL

Cells	NULL
(	NULL
40	NULL
x	NULL
10°/experiment	NULL
)	NULL
were	NULL
washed	NULL
two	NULL
times	NULL
in	NULL
phosphate-free	NULL
buffer	NULL
(	NULL
PFB	NULL
;	NULL
140	NULL
mM	NULL
NaC1/5.4	NULL
mM	NULL
KCI/1.8	NULL
mM	NULL
CaC1	NULL
;	NULL
/0.8	NULL
mM	NULL
MgS	NULL
$	NULL
O4/5.5	NULL
mM	NULL
glucose/20	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.35	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
in	NULL
phosphate-free	NULL
medium	NULL
(	NULL
PFM	NULL
;	NULL
GIBCO/BRL	NULL
,	NULL
no	NULL
.	NULL

11877-032	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
45	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
spun	NULL
down	NULL
(	NULL
500	NULL
%	NULL
g	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
8	NULL
ml	NULL
of	NULL
PFM	NULL
supplemented	NULL
with	NULL
1.5	NULL
mCi	NULL
of	NULL
[	NULL
}	NULL
PJorthophosphate	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
,	NULL
PBS11	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
37°C	NULL
.	NULL

CA	NULL
or	NULL
CyA	NULL
were	NULL
added	NULL
,	NULL
and	NULL
cells	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
_	NULL
10621	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
1	NULL
hr	NULL
.	NULL

Cells	NULL
hereafter	NULL
were	NULL
spun	NULL
down	NULL
(	NULL
500	NULL
x	NULL
g	NULL
)	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
ice-cold	NULL
PFB	NULL
wash	NULL
buffer	NULL
[	NULL
1	NULL
part	NULL
(	NULL
wt/wt	NULL
)	NULL
PFB/10	NULL
mM	NULL
EDTA/S5	NULL
mM	NULL
EGTA/10	NULL
mM	NULL
NaF/1	NULL
mM	NULL
NasVO4	NULL
)	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
phosphorylation	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100/10	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
7.5/150	NULL
mM	NULL
NaCl/10	NULL
mM	NULL
EDTA/5	NULL
mM	NULL
EGTA/10	NULL
mM	NULL
NaF/1	NULL
mM	NULL
Na	NULL
;	NULL
VO4/1	NULL
mM	NULL
PMSF	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
.	NULL

°P-labeled	NULL
STAT3	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
15	NULL
ul	NULL
of	NULL
anti-human	NULL
STAT3	NULL
pAb	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Thin-Layer	NULL
Electrophoresis	NULL
of	NULL
Phosphoamino	NULL
Acids	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
boiled	NULL
in	NULL
25	NULL
wl	NULL
of	NULL
SDS-sample	NULL
buffer	NULL
[	NULL
0.06	NULL
M	NULL
TrisHCl	NULL
,	NULL
pH	NULL
6.8/10	NULL
%	NULL
glycerol/2	NULL
%	NULL
(	NULL
wt/wt	NULL
)	NULL
SDS/1	NULL
%	NULL
DTT/0.002	NULL
%	NULL
bromphenol	NULL
blue	NULL
)	NULL
for	NULL
5	NULL
min	NULL
.	NULL

They	NULL
then	NULL
were	NULL
loaded	NULL
and	NULL
run	NULL
on	NULL
Precast	NULL
12	NULL
%	NULL
Tris-glycine	NULL
gels	NULL
(	NULL
EC6005	NULL
,	NULL
NOVEX	NULL
,	NULL
San	NULL
Diego	NULL
)	NULL
according	NULL
to	NULL
standard	NULL
minigel	NULL
procedures	NULL
for	NULL
the	NULL
Novex	NULL
XCell	NULL
II	NULL
Mini-Cell	NULL
(	NULL
E19001	NULL
)	NULL
system	NULL
.	NULL

SeeBlue	NULL
PreStained	NULL
Standards	NULL
(	NULL
NOVEX	NULL
)	NULL
were	NULL
used	NULL
as	NULL
molecular	NULL
weight	NULL
markers	NULL
.	NULL

Resolved	NULL
profiles	NULL
and	NULL
molecular	NULL
weight	NULL
markers	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
from	NULL
SDS/PAGE	NULL
gel	NULL
onto	NULL
poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
(	NULL
PVDF	NULL
)	NULL
membrane	NULL
according	NULL
to	NULL
the	NULL
NOVEX	NULL
Western	NULL
transfer	NULL
apparatus	NULL
instructions	NULL
for	NULL
the	NULL
NOVEX	NULL
blot	NULL
module	NULL
(	NULL
E19051	NULL
)	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
overnight	NULL
without	NULL
a	NULL
screen	NULL
.	NULL

32P-labeled	NULL
proteins	NULL
of	NULL
interest	NULL
were	NULL
cut	NULL
out	NULL
from	NULL
the	NULL
PVDF	NULL
membrane	NULL
and	NULL
incubated	NULL
in	NULL
6	NULL
M	NULL
HCl	NULL
for	NULL
2	NULL
min	NULL
at	NULL
100°C	NULL
.	NULL

The	NULL
samples	NULL
then	NULL
were	NULL
vortexed	NULL
followed	NULL
by	NULL
hydrolysis	NULL
at	NULL
110°C	NULL
for	NULL
60	NULL
min	NULL
and	NULL
dried	NULL
with	NULL
a	NULL
flow	NULL
of	NULL
nitrogen	NULL
.	NULL

The	NULL
samples	NULL
then	NULL
were	NULL
added	NULL
to	NULL
10	NULL
ul	NULL
of	NULL
H	NULL
,	NULL
O	NULL
and	NULL
run	NULL
on	NULL
20	NULL
X	NULL
20-cm	NULL
cellulose	NULL
k-2F	NULL
plates	NULL
(	NULL
60	NULL
mA	NULL
,	NULL
55	NULL
min	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
o-phosphoamino	NULL
acid	NULL
markers	NULL
.	NULL

The	NULL
markers	NULL
were	NULL
visualized	NULL
by	NULL
spraying	NULL
the	NULL
plate	NULL
with	NULL
ninhydrin	NULL
and	NULL
o-phtalaldehyde	NULL
,	NULL
the	NULL
latter	NULL
procedure	NULL
showing	NULL
selective	NULL
fluorescence	NULL
of	NULL
phosphotyrosine	NULL
in	NULL
UV	NULL
light	NULL
.	NULL

The	NULL
labeled	NULL
phosphoamino	NULL
acids	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

Confocal	NULL
Laser	NULL
Scanning	NULL
Microscopy	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
inhibitors	NULL
as	NULL
indicated	NULL
before	NULL
fixation	NULL
(	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
PBS	NULL
)	NULL
.	NULL

Intracellular	NULL
staining	NULL
for	NULL
STAT3	NULL
using	NULL
a	NULL
STAT3	NULL
pAb	NULL
(	NULL
#	NULL
9132	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Confocal	NULL
laser	NULL
scanning	NULL
microscopy	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Zeiss	NULL
CLSM	NULL
310	NULL
.	NULL

An	NULL
argon	NULL
laser	NULL
(	NULL
488	NULL
nm	NULL
)	NULL
was	NULL
used	NULL
for	NULL
FITC	NULL
fluorescence	NULL
and	NULL
a	NULL
HeNe	NULL
laser	NULL
(	NULL
543	NULL
nm	NULL
)	NULL
for	NULL
transmitted	NULL
light	NULL
interference	NULL
contrast	NULL
.	NULL

Objective	NULL
was	NULL
40	NULL
%	NULL
/numerical	NULL
aperture	NULL
1.2	NULL
water	NULL
immersion	NULL
.	NULL

RESULTS	NULL
CA	NULL
Induces	NULL
Serine	NULL
Phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
PP1/PP2A	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
CA	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
,	NULL
and	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
total	NULL
cell	NULL
lysates	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-STAT3	NULL
phosphoserine-727	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
Upper	NULL
,	NULL
CA	NULL
induces	NULL
a	NULL
concentration-dependent	NULL
increase	NULL
of	NULL
serine-phosphorylated	NULL
STAT3	NULL
.	NULL

CD4*	NULL
T	NULL
cell	NULL
lines	NULL
express	NULL
large	NULL
amounts	NULL
of	NULL
a	NULL
high	NULL
molecular	NULL
weight	NULL
isoform	NULL
of	NULL
STAT3	NULL
,	NULL
STAT3a	NULL
,	NULL
and	NULL
low	NULL
amounts	NULL
of	NULL
a	NULL
low	NULL
molecular	NULL
weight	NULL
isoform	NULL
,	NULL
STAT3B	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14A	NULL
Upper	NULL
,	NULL
CA	NULL
induced	NULL
an	NULL
increased	NULL
serine	NULL
phosphorylation	NULL
of	NULL
both	NULL
isoforms	NULL
.	NULL

CA	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
induce	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
Lower	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
inhibition	NULL
of	NULL
PP1/PP2A	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
phosphoserine	NULL
STAT3	NULL
to	NULL
total	NULL
STAT3	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
phosphoserine	NULL
STAT3	NULL
was	NULL
paralleled	NULL
by	NULL
a	NULL
gradual	NULL
decrease	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3	NULL
,	NULL
which	NULL
was	NULL
most	NULL
prominent	NULL
at	NULL
80	NULL
nM	NULL
of	NULL
CA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
Lower	NULL
)	NULL
.	NULL

Higher	NULL
concentrations	NULL
of	NULL
CA	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
further	NULL
decrease	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
or	NULL
increase	NULL
in	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
effect	NULL
of	NULL
CA	NULL
on	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
observed	NULL
in	NULL
cutaneous	NULL
T	NULL
cell	NULL
lymphoma	NULL
lines	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
our	NULL
findings	NULL
10622	NULL
-	NULL
Biochemistry	NULL
:	NULL
Woetmann	NULL
et	NULL
al	NULL
.	NULL

|Calyculil1A	NULL
(	NULL
lM	NULL
)	NULL
=-	NULL
5	NULL
10	NULL
20	NULL
40	NULL
80	NULL
=	NULL
Blot	NULL
:	NULL
STAT3	NULL
ps	NULL
727	NULL
°	NULL
``	NULL
|-	NULL
\|	NULL
«	NULL
me	NULL
dase	NULL
ale	NULL
lk	NULL
sing	NULL
Blot	NULL
:	NULL
STAT3	NULL
_	NULL
*	NULL
``	NULL
|	NULL
semen	NULL
nene	NULL
wae	NULL
mmr	NULL
mr	NULL
ames	NULL
|	NULL
G-IP	NULL
:	NULL
a-STAT3	NULL
lemma	NULL
e	NULL
+	NULL
-	NULL
®	NULL
(	NULL
0	NULL
)	NULL
pT	NULL
g	NULL
|	NULL
pT	NULL
;	NULL
l	NULL
:	NULL
-	NULL
``	NULL
&	NULL
``	NULL
``	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
CA	NULL
induces	NULL
serine	NULL
phosphoryaltion	NULL
of	NULL
STAT3	NULL
in	NULL
vivo	NULL
.	NULL

Resting	NULL
,	NULL
antigen-specific	NULL
human	NULL
CD4+*	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
CA	NULL
(	NULL
5-80	NULL
nM	NULL
)	NULL
for	NULL
60	NULL
min	NULL
,	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
applied	NULL
to	NULL
SDS/PAGE	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
pS	NULL
$	NULL
727	NULL
(	NULL
Upper	NULL
)	NULL
,	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Amino	NULL
acid	NULL
analysis	NULL
of	NULL
32P-orthophosphate-labeled	NULL
STAT3	NULL
.	NULL

P-labeled	NULL
proteins	NULL
of	NULL
interest	NULL
,	NULL
representing	NULL
STAT3	NULL
proteins	NULL
from	NULL
cutaneous	NULL
T	NULL
lymphoma	NULL
cells	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
CA	NULL
for	NULL
60	NULL
min	NULL
,	NULL
were	NULL
cut	NULL
out	NULL
from	NULL
the	NULL
poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
membrane	NULL
,	NULL
hydrolyzed	NULL
in	NULL
6	NULL
M	NULL
HCI	NULL
,	NULL
and	NULL
separated	NULL
by	NULL
thin-layer	NULL
electrophoresis	NULL
.	NULL

The	NULL
P-labeled	NULL
phosphoamino	NULL
acids	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

with	NULL
the	NULL
anti-STAT3	NULL
phosphoserine-727	NULL
antibody	NULL
,	NULL
T	NULL
lymphoma	NULL
cells	NULL
were	NULL
loaded	NULL
with	NULL
*P-orthophosphate	NULL
and	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
CA	NULL
before	NULL
immunoprecipitation	NULL
of	NULL
STAT3	NULL
.	NULL

Immune-purified	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
12	NULL
%	NULL
Tris-glycine	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Phosphoamino	NULL
acid	NULL
analysis	NULL
of	NULL
the	NULL
immune-purified	NULL
STAT3	NULL
from	NULL
P-labeled	NULL
cells	NULL
showed	NULL
that	NULL
CA	NULL
induced	NULL
a	NULL
profound	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CA	NULL
induced	NULL
threonine	NULL
(	NULL
but	NULL
not	NULL
tyrosine	NULL
)	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Calyculin	NULL
A	NULL
(	NULL
min	NULL
)	NULL
--	NULL
1	NULL
5	NULL
15	NULL
30	NULL
60	NULL
-	NULL
=-Cyclosporin	NULL
A	NULL
(	NULL
min	NULL
)	NULL
woe	NULL
ee	NULL
ee	NULL
ee	NULL
e	NULL
e	NULL
60	NULL
Blot	NULL
:	NULL
STAT3	NULL
pS	NULL
727	NULL
f	NULL
,	NULL
-——q-._	NULL
oak	NULL
Blot	NULL
:	NULL
STAT3	NULL
(	NULL
21320	NULL
)	NULL
Blot	NULL
:	NULL
STAT3	NULL
(	NULL
K-15	NULL
)	NULL
Blot	NULL
:	NULL
STATS	NULL
911	NULL
B	NULL
|	NULL
PPase	NULL
inhibitor	NULL
-	NULL
TAU	NULL
-	NULL
OA	NULL
=	NULL
&	NULL
ETA	NULL
-	NULL
CA	NULL
L	NULL
CyA	NULL
9	NULL
?	NULL

-	NULL
!	NULL

a	NULL
97	NULL
Blot	NULL
:	NULL
STAT3	NULL
pS	NULL
727	NULL
Blot	NULL
:	NULL
STAT3	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A4	NULL
)	NULL
Inhibition	NULL
of	NULL
PP1/PP2A	NULL
induces	NULL
rapid	NULL
(	NULL
<	NULL
1	NULL
hr	NULL
)	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

T	NULL
lymphoma	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
or	NULL
CyA	NULL
(	NULL
400	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
5-60	NULL
min	NULL
,	NULL
lysed	NULL
,	NULL
applied	NULL
to	NULL
SDS/	NULL
PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
pS	NULL
727	NULL
pAb	NULL
,	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
(	NULL
$	NULL
21320	NULL
)	NULL
,	NULL
anti-STAT3	NULL
(	NULL
K-15	NULL
)	NULL
,	NULL
and	NULL
anti-STATS	NULL
.	NULL

(	NULL
B	NULL
)	NULL
PP2A-specific	NULL
,	NULL
but	NULL
not	NULL
a	NULL
PP1-specific	NULL
,	NULL
inhibitor	NULL
,	NULL
induced	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
.	NULL

T	NULL
lymphoma	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
either	NULL
TAU	NULL
(	NULL
500	NULL
nM	NULL
)	NULL
,	NULL
OA	NULL
(	NULL
500	NULL
nM	NULL
)	NULL
,	NULL
ETA	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
,	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
,	NULL
or	NULL
CyA	NULL
(	NULL
400	NULL
ng/ml	NULL
)	NULL
for	NULL
60	NULL
min	NULL
,	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
applied	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
p	NULL
$	NULL
727	NULL
(	NULL
Upper	NULL
)	NULL
and	NULL
stripped	NULL
,	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
«	NULL
and	NULL
STAT3B	NULL
was	NULL
rapid	NULL
(	NULL
1-5	NULL
min	NULL
)	NULL
,	NULL
reaching	NULL
a	NULL
maximum	NULL
after	NULL
60	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Top	NULL
)	NULL
.	NULL

Incubation	NULL
with	NULL
CA	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
decrease	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3a	NULL
«	NULL
and	NULL
STAT3RB	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Middle	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
change	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3	NULL
«	NULL
was	NULL
significantly	NULL
larger	NULL
than	NULL
that	NULL
of	NULL
STAT3B	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Middle	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
STAT3	NULL
«	NULL
is	NULL
more	NULL
heavily	NULL
serine/threonine-phosphorylated	NULL
than	NULL
STAT3B	NULL
.	NULL

Because	NULL
both	NULL
isoforms	NULL
of	NULL
STAT3	NULL
were	NULL
phosphorylated	NULL
on	NULL
serine-727	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Top	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
CA	NULL
induces	NULL
phosphorylation	NULL
of	NULL
additional	NULL
serine	NULL
(	NULL
or	NULL
threonine	NULL
)	NULL
residues	NULL
.	NULL

To	NULL
address	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
or	NULL
not	NULL
PP1/PP2A	NULL
inhibition	NULL
by	NULL
CA	NULL
had	NULL
an	NULL
effect	NULL
on	NULL
other	NULL
STAT	NULL
proteins	NULL
and/or	NULL
other	NULL
serine/theronine	NULL
kinase	NULL
substrates	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
an	NULL
antibody	NULL
that	NULL
recognizes	NULL
two	NULL
related	NULL
STATS	NULL
proteins	NULL
,	NULL
STAT	NULL
5a	NULL
and	NULL
STAT5b	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Bottom	NULL
,	NULL
CA	NULL
induced	NULL
an	NULL
decrease	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
STAT	NULL
5b	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CA	NULL
did	NULL
not	NULL
induce	NULL
a	NULL
change	NULL
the	NULL
mobility	NULL
of	NULL
STATS5a	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
Bottom	NULL
)	NULL
,	NULL
TYK2	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
phospholipase	NULL
C-17	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
only	NULL
observed	NULL
an	NULL
induction	NULL
of	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
when	NULL
CA	NULL
was	NULL
added	NULL
to	NULL
intact	NULL
,	NULL
living	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
added	NULL
to	NULL
cell	NULL
lysates	NULL
,	NULL
CA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
STAT	NULL
phosphorylation	NULL
even	NULL
at	NULL
concentrations	NULL
(	NULL
400	NULL
nM	NULL
)	NULL
that	NULL
inhibited	NULL
PP1/PP2A	NULL
activity	NULL
by	NULL
98	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PP2A	NULL
,	NULL
But	NULL
Not	NULL
PP1	NULL
and	NULL
PP2B	NULL
,	NULL
Inhibitors	NULL
Induces	NULL
Serine	NULL
Phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

CyA	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
serine/	NULL
theronine	NULL
phosphatases	NULL
PP2B	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
8	NULL
from	NULL
left	NULL
)	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
either	NULL
STAT3	NULL
«	NULL
or	NULL
STAT3B	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lane	NULL
8	NULL
from	NULL
left	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
at	NULL
concentrations	NULL
(	NULL
800	NULL
ng/ml	NULL
)	NULL
that	NULL
blocked	NULL
CD3	NULL
mAb-induced	NULL
proliferation	NULL
,	NULL
CyA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
PP1/PP2A	NULL
activity	NULL
or	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
,	NULL
and	NULL
CyA	NULL
did	NULL
not	NULL
modulate	NULL
the	NULL
CA	NULL
response	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
PP1	NULL
,	NULL
PP2A	NULL
,	NULL
or	NULL
both	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
,	NULL
we	NULL
took	NULL
advantage	NULL
of	NULL
inhibitors	NULL
with	NULL
different	NULL
PP	NULL
specificity	NULL
:	NULL
(	NULL
?	NULL
)	NULL

OA	NULL
and	NULL
ETA	NULL
,	NULL
both	NULL
of	NULL
which	NULL
predominantly	NULL
inhibit	NULL
PP2A	NULL
(	NULL
31-33	NULL
)	NULL
,	NULL
(	NULL
i	NULL
)	NULL
TAU	NULL
,	NULL
which	NULL
predominantly	NULL
inhibits	NULL
PP1	NULL
(	NULL
31	NULL
,	NULL
33	NULL
)	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
CA	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
both	NULL
PP1	NULL
and	NULL
PP2A	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
CyA	NULL
,	NULL
a	NULL
selective	NULL
inhibitor	NULL
of	NULL
PP2B	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
Upper	NULL
,	NULL
CA	NULL
,	NULL
OK	NULL
,	NULL
and	NULL
ETA	NULL
induced	NULL
comparable	NULL
levels	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
and	NULL
a	NULL
corresponding	NULL
decrease	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
Lower	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
PP1	NULL
inhibitor	NULL
,	NULL
TAU	NULL
,	NULL
did	NULL
not	NULL
induce	NULL
serine	NULL
phosphorylation	NULL
or	NULL
a	NULL
decreased	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
at	NULL
concentrations	NULL
that	NULL
blocked	NULL
cytokine-mediated	NULL
proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
PP2A	NULL
,	NULL
but	NULL
not	NULL
PP1	NULL
and	NULL
PP2B	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
.	NULL

This	NULL
conclusion	NULL
agrees	NULL
with	NULL
the	NULL
recent	NULL
observation	NULL
that	NULL
PP2A	NULL
,	NULL
but	NULL
not	NULL
PP1	NULL
,	NULL
dephosphorylates	NULL
serine-phosphorylated	NULL
STAT3	NULL
in	NULL
vitro	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Staurosporine	NULL
Inhibits	NULL
CA-Induced	NULL
Serine	NULL
Phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

Several	NULL
cytokines	NULL
induce	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
via	NULL
the	NULL
MEK-MAPK	NULL
(	NULL
ERK	NULL
)	NULL
pathway	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
PP2A	NULL
inhibitor	NULL
,	NULL
OK	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
MAPK	NULL
(	NULL
ERK	NULL
)	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
CA	NULL
induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
via	NULL
the	NULL
MEK-MAPK	NULL
pathway	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
both	NULL
CA	NULL
and	NULL
OK	NULL
induced	NULL
activation	NULL
of	NULL
MAP	NULL
(	NULL
p42/44	NULL
ERK	NULL
)	NULL
and	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
almost	NULL
completely	NULL
blocked	NULL
CA-induced	NULL
p42/44	NULL
ERK	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lane	NULL
2	NULL
from	NULL
left	NULL
versus	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
PD98059	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

Likewise	NULL
,	NULL
PD98059	NULL
strongly	NULL
inhibited	NULL
OK-induced	NULL
ERK/MAPK	NULL
activation	NULL
but	NULL
not	NULL
induction	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
,	NULL
suggesting	NULL
that	NULL
ERK/MAPKs	NULL
are	NULL
not	NULL
involved	NULL
in	NULL
CA/OK-induced	NULL
STAT3	NULL
phosphorylation	NULL
.	NULL

H7	NULL
,	NULL
a	NULL
broadly	NULL
reacting	NULL
serine/threonine	NULL
kinase	NULL
inhibitor	NULL
,	NULL
also	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
Biochemistry	NULL
:	NULL
Woetmann	NULL
et	NULL
al	NULL
.	NULL

PPase	NULL
inhibitor	NULL
CA	NULL
CA	NULL
CyA	NULL
CyA	NULL
OA	NULL
OA	NULL
_	NULL
_	NULL
PDO98059	NULL
_	NULL
$	NULL
e	NULL
$	NULL
os	NULL
$	NULL
os	NULL
%	NULL
Blot	NULL
:	NULL
Phosp	NULL
.	NULL

p42/44-ERK	NULL
|	NULL
aam	NULL
-_	NULL
..__._opmen	NULL
Blot	NULL
:	NULL
p42/44-ERK	NULL
Blot	NULL
star3ps	NULL
727	NULL
_	NULL
|	NULL
ae	NULL
___	NULL
ae	NULL
-	NULL
___|	NULL
Blot	NULL
:	NULL
STAT3	NULL
*P	NULL
r	NULL
DGH	NULL
one	NULL
wes	NULL
Enzyme	NULL
inhibitor	NULL
=-	NULL
=	NULL
H7	NULL
H7	NULL
PD	NULL
PD	NULL
STA	NULL
STA	NULL
==	NULL
=	NULL
Cyclosporine	NULL
A	NULL
=	NULL
=	NULL
ooo	NULL
«	NULL
o	NULL
4	NULL
Calyculin	NULL
A	NULL
£	NULL
'+	NULL
&	NULL
Blot	NULL
:	NULL
STAT3	NULL
pS	NULL
727	NULL
Blot	NULL
:	NULL
STAT3	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
PD98059	NULL
inhibits	NULL
CA-induced	NULL
activation	NULL
of	NULL
ERK	NULL
p42/44	NULL
,	NULL
but	NULL
not	NULL
CA-induced	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
.	NULL

T	NULL
lymphoma	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
or	NULL
without	NULL
a	NULL
MEK	NULL
inhibitor	NULL
:	NULL
PD98059	NULL
at	NULL
50	NULL
uM	NULL
for	NULL
60	NULL
min	NULL
,	NULL
before	NULL
incubation	NULL
with	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
,	NULL
OA	NULL
(	NULL
500	NULL
nM	NULL
)	NULL
,	NULL
or	NULL
CyA	NULL
(	NULL
400	NULL
ng/ml	NULL
!	NULL
)	NULL

for	NULL
60	NULL
min	NULL
,	NULL
lysed	NULL
and	NULL
applied	NULL
to	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-phospho-p42/44	NULL
ERK	NULL
,	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-p42/44	NULL
ERK	NULL
,	NULL
anti-STAT3	NULL
p	NULL
$	NULL
727	NULL
,	NULL
or	NULL
anti-STAT3	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inhibition	NULL
of	NULL
staurosporine-sensitive	NULL
kinases	NULL
inhibits	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
antigen-specific	NULL
human	NULL
CD4+*	NULL
T	NULL
cells	NULL
were	NULL
preincubated	NULL
in	NULL
either	NULL
medium	NULL
H7	NULL
at	NULL
200	NULL
uM	NULL
,	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
at	NULL
50	NULL
wM	NULL
(	NULL
PD	NULL
)	NULL
,	NULL
or	NULL
staurosporine	NULL
(	NULL
STA	NULL
)	NULL
at	NULL
100	NULL
nM	NULL
for	NULL
60	NULL
min	NULL
before	NULL
incubation	NULL
in	NULL
medium	NULL
,	NULL
the	NULL
PP1/PP2A-specific	NULL
inhibitor	NULL
CA	NULL
at	NULL
80	NULL
nM	NULL
or	NULL
the	NULL
PP2B-specific	NULL
inhibitor	NULL
CyA	NULL
at	NULL
400	NULL
ng/ml	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
applied	NULL
to	NULL
SDS/PAGE	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
p	NULL
$	NULL
727	NULL
(	NULL
Upper	NULL
)	NULL
and	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

inhibit	NULL
cytokine-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
preincuabtion	NULL
with	NULL
H7	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
preincubation	NULL
with	NULL
the	NULL
broad	NULL
serine/threonine	NULL
kinase	NULL
inhibitor	NULL
staurosporine	NULL
(	NULL
35	NULL
)	NULL
profoundly	NULL
inhibited	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
«	NULL
and	NULL
STAT3B	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Staurosporine	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
level	NULL
of	NULL
constitutively	NULL
tyrosine-phosphorylated	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
inhibitors	NULL
of	NULL
serine/threonine	NULL
kinases	NULL
such	NULL
as	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
wortmannin	NULL
,	NULL
LY294002	NULL
)	NULL
and	NULL
p38-MAPK	NULL
(	NULL
SB203580	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
CA-induced	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CA	NULL
Modulates	NULL
the	NULL
Function	NULL
and	NULL
Subcellular	NULL
Distribution	NULL
of	NULL
STAT3	NULL
.	NULL

As	NULL
mentioned	NULL
earlier	NULL
,	NULL
STAT3	NULL
is	NULL
constitutively	NULL
tyrosine-phosphorylated	NULL
in	NULL
certain	NULL
cutaneous	NULL
T	NULL
lymphoma	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
36	NULL
)	NULL
,	NULL
and	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
CA	NULL
induced	NULL
a	NULL
time-dependent	NULL
inhibition	NULL
of	NULL
the	NULL
level	NULL
of	NULL
tyrosine-phosphorylated	NULL
STAT3	NULL
whereas	NULL
CyA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
STAT3	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
Top	NULL
,	NULL
lane	NULL
8	NULL
from	NULL
left	NULL
)	NULL
.	NULL

The	NULL
CA-induced	NULL
decrease	NULL
in	NULL
phosphotyrosine	NULL
STAT3	NULL
was	NULL
observed	NULL
after	NULL
a	NULL
lag	NULL
period	NULL
of	NULL
30-60	NULL
min	NULL
and	NULL
always	NULL
was	NULL
preceded	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
phosphoserine	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
Middle	NULL
)	NULL
.	NULL

It	NULL
previously	NULL
was	NULL
shown	NULL
(	NULL
22	NULL
)	NULL
that	NULL
the	NULL
constitutively	NULL
tyrosine-phosphorylated	NULL
STAT3	NULL
«	NULL
proteins	NULL
isolated	NULL
from	NULL
cutaneous	NULL
T	NULL
lymphoma	NULL
cells	NULL
bind	NULL
oligonucleotide	NULL
sequences	NULL
corresponding	NULL
to	NULL
the	NULL
GASd	NULL
and	NULL
GASp	NULL
elements	NULL
in	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
,	NULL
the	NULL
hSIE	NULL
element	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
pIRE	NULL
element	NULL
in	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
promoter	NULL
,	NULL
all	NULL
of	NULL
which	NULL
contain	NULL
a	NULL
STAT3	NULL
binding	NULL
motif	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

37	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
CA	NULL
almost	NULL
completely	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
STAT3a	NULL
to	NULL
the	NULL
GASd	NULL
and	NULL
GASp	NULL
probes	NULL
.	NULL

Likewise	NULL
,	NULL
CA	NULL
induced	NULL
a	NULL
profound	NULL
inhibition	NULL
of	NULL
STAT3a	NULL
«	NULL
binding	NULL
to	NULL
the	NULL
hSIE	NULL
and	NULL
pIRE	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CA	NULL
had	NULL
only	NULL
a	NULL
weak	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
STAT3	NULL
$	NULL
to	NULL
the	NULL
hSIE	NULL
and	NULL
ICAM-1	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
_	NULL
10623	NULL
Calyculin	NULL
A	NULL
(	NULL
min	NULL
)	NULL
=-	NULL
10	NULL
5	NULL
15	NULL
30	NULL
60	NULL
-	NULL
Cyclosporin	NULL
A	NULL
(	NULL
min	NULL
)	NULL
woo	NULL
o_	NULL
ok	NULL
oe	NULL
oe	NULL
o-	NULL
60	NULL
Blot	NULL
:	NULL
STAT	NULL
3	NULL
pY	NULL
705	NULL
womens	NULL
CMe	NULL
97	NULL
(	NULL
-Blot	NULL
:	NULL
STAT3	NULL
pS	NULL
727	NULL
raye	NULL
I	NULL
‘	NULL
E	NULL
97=	NULL
Blot	NULL
STaT3	NULL
comment	NULL
B	NULL
DNA-probe	NULL
GASd	NULL
-	NULL
GASp	NULL
-	NULL
hSIE	NULL
_	NULL
pIRE	NULL
Calyculin	NULL
A	NULL
=o	NULL
t	NULL
-	NULL
to-	NULL
$	NULL
o	NULL
-o	NULL
4	NULL
57	NULL
fe	NULL
Blot	NULL
:	NULL
STAT3	NULL
-	NULL
«	NULL
a	NULL
»	NULL
«	NULL
a	NULL
=_-	NULL
;	NULL
_§r	NULL
:	NULL
:	NULL
ﬁs	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

CA	NULL
inhibits	NULL
the	NULL
function	NULL
of	NULL
STAT3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
CA-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
precedes	NULL
decrease	NULL
in	NULL
phospho-tyrosine	NULL
STAT3	NULL
.	NULL

T	NULL
lymphoma	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
or	NULL
CyA	NULL
(	NULL
400	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
1-60	NULL
min	NULL
,	NULL
lysed	NULL
,	NULL
applied	NULL
to	NULL
SDS/PAGE	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
pY705	NULL
(	NULL
Top	NULL
)	NULL
,	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
pS	NULL
$	NULL
727	NULL
(	NULL
Middle	NULL
)	NULL
,	NULL
or	NULL
anti-STAT3	NULL
(	NULL
Bottom	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Inhibition	NULL
of	NULL
PP2A	NULL
by	NULL
CA	NULL
inhibits	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
from	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
T	NULL
lymphoma	NULL
cells	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
for	NULL
60	NULL
min	NULL
were	NULL
analyzed	NULL
by	NULL
affinity	NULL
purification	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
using	NULL
biotinylated	NULL
DNA	NULL
probes	NULL
[	NULL
IL-2R	NULL
«	NULL
(	NULL
GASd	NULL
or	NULL
GASp	NULL
)	NULL
]	NULL
,	NULL
c-fos	NULL
(	NULL
hSIE	NULL
)	NULL
,	NULL
or	NULL
ICAM-1	NULL
(	NULL
pIRE	NULL
)	NULL
]	NULL
.	NULL

STAT/DNA	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-STAT3	NULL
mAb	NULL
.	NULL

lanes	NULL
6	NULL
and	NULL
8	NULL
from	NULL
left	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
two	NULL
STAT3	NULL
isoforms	NULL
might	NULL
be	NULL
regulated	NULL
differently	NULL
by	NULL
PP2A	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

54	NULL
Top	NULL
,	NULL
STAT3	NULL
is	NULL
widely	NULL
distributed	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
,	NULL
and	NULL
most	NULL
notably	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
STAT3	NULL
expression	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

CA	NULL
induced	NULL
a	NULL
profound	NULL
change	NULL
in	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
.	NULL

Thus	NULL
,	NULL
after	NULL
CA	NULL
treatment	NULL
,	NULL
STAT3	NULL
was	NULL
found	NULL
almost	NULL
exclusively	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
whereas	NULL
virtually	NULL
no	NULL
STAT3	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
Middle	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CyA	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
Bottom	NULL
)	NULL
.	NULL

The	NULL
CA-induced	NULL
change	NULL
in	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
was	NULL
observed	NULL
as	NULL
early	NULL
as	NULL
5	NULL
min	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
simultaneously	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
STAT3	NULL
serine/threonine	NULL
phosphorylation	NULL
but	NULL
before	NULL
the	NULL
decrease	NULL
in	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
Top	NULL
vs.	NULL
Middle	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
these	NULL
findings	NULL
,	NULL
T	NULL
lymphoma	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
inhibitors	NULL
as	NULL
above	NULL
before	NULL
cell	NULL
fractioning	NULL
and	NULL
Western	NULL
blotting	NULL
with	NULL
anti-Stat3	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
CA	NULL
triggered	NULL
strong	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
an	NULL
almost	NULL
complete	NULL
disappearance	NULL
of	NULL
STAT3	NULL
from	NULL
the	NULL
nuclear	NULL
fraction	NULL
whereas	NULL
CyA	NULL
did	NULL
not	NULL
induce	NULL
serine	NULL
phosphorylation	NULL
and	NULL
redistribution	NULL
of	NULL
STAT3	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
PPs	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
,	NULL
subcellular	NULL
distribution	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
show	NULL
that	NULL
CA	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
both	NULL
PP1	NULL
and	NULL
PP2A	NULL
,	NULL
induced	NULL
serine-727	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
,	NULL
whereas	NULL
CyA	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
PP2B	NULL
,	NULL
did	NULL
not	NULL
.	NULL

Two	NULL
structurally	NULL
different	NULL
PP2A	NULL
inhibitors	NULL
,	NULL
OK	NULL
and	NULL
ETA	NULL
,	NULL
also	NULL
induced	NULL
a	NULL
profound	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
,	NULL
whereas	NULL
the	NULL
PP1	NULL
inhibitor	NULL
,	NULL
TAU	NULL
,	NULL
did	NULL
not	NULL
.	NULL

Furthermore	NULL
,	NULL
PP2A	NULL
inhibitors	NULL
induced	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
of	NULL
STATS5Sb	NULL
but	NULL
not	NULL
of	NULL
STATS5a	NULL
,	NULL
TYK2	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
unrelated	NULL
proteins	NULL
such	NULL
as	NULL
phospholipase	NULL
C-y1	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effect	NULL
on	NULL
STAT3	NULL
and	NULL
STATS5b	NULL
was	NULL
highly	NULL
specific	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
effect	NULL
on	NULL
serine	NULL
phosphorylation	NULL
,	NULL
PP2A	NULL
inhibitors	NULL
induced	NULL
threonine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
whether	NULL
threonine	NULL
phosphorylation	NULL
10624	NULL
_	NULL
Biochemistry	NULL
:	NULL
Woetmann	NULL
et	NULL
al	NULL
.	NULL

A	NULL
Cytoplasm	NULL
Nucleus	NULL
Calyculin	NULL
A	NULL
-o	NULL
$	NULL
00	NULL
-	NULL
-o	NULL
+	NULL
Cyclosporin	NULL
A	NULL
+	NULL
-	NULL
-	NULL
+	NULL
Blot	NULL
Stata	NULL
ps	NULL
11	NULL
7	NULL
)	NULL
--	NULL
emil	NULL
97	NULL
)	NULL
-Blot	NULL
.	NULL

STAT3	NULL
axsin	NULL
~-	NULL
wuss	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Inhibition	NULL
of	NULL
PP2A	NULL
modulates	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Confocal	NULL
laser	NULL
scanning	NULL
microscopy	NULL
analysis	NULL
of	NULL
STAT3	NULL
location	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
incubated	NULL
with	NULL
solvent	NULL
(	NULL
media	NULL
,	NULL
Top	NULL
)	NULL
,	NULL
80	NULL
nM	NULL
CA	NULL
(	NULL
Middle	NULL
)	NULL
,	NULL
or	NULL
400	NULL
ng/ml	NULL
CyA	NULL
(	NULL
Bottom	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
and	NULL
stained	NULL
with	NULL
anti-STAT3	NULL
(	NULL
#	NULL
9132	NULL
)	NULL
followed	NULL
by	NULL
confocal	NULL
laser	NULL
scanning	NULL
microscopy	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Green	NULL
fluorescence	NULL
.	NULL

(	NULL
Center	NULL
)	NULL
Blue	NULL
interference	NULL
contrast	NULL
.	NULL

(	NULL
Leff	NULL
)	NULL
combination	NULL
of	NULL
both	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Serine	NULL
phosphorylation	NULL
inhibits	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT3	NULL
.	NULL

Cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
T	NULL
lymphoma	NULL
cells	NULL
incubated	NULL
in	NULL
medium	NULL
CA	NULL
(	NULL
80	NULL
nM	NULL
)	NULL
or	NULL
CyA	NULL
(	NULL
400	NULL
ng/ml	NULL
)	NULL
for	NULL
60	NULL
min	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
anti-STAT3	NULL
pS	NULL
$	NULL
727	NULL
(	NULL
Upper	NULL
)	NULL
and	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT3	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

modulates	NULL
the	NULL
function	NULL
of	NULL
STAT3	NULL
,	NULL
but	NULL
in	NULL
a	NULL
recent	NULL
study	NULL
,	NULL
Chung	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
observed	NULL
that	NULL
epidermal	NULL
growth	NULL
factor-induced	NULL
threonine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
COS	NULL
cells	NULL
transiently	NULL
expressing	NULL
STAT3	NULL
.	NULL

It	NULL
therefore	NULL
is	NULL
possible	NULL
that	NULL
threonine	NULL
phosphorylation	NULL
plays	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
STAT3	NULL
signaling	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effect	NULL
on	NULL
serine	NULL
and	NULL
threonine	NULL
phosphorylation	NULL
,	NULL
CA	NULL
did	NULL
not	NULL
induce	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
residues	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
CA	NULL
profoundly	NULL
inhibited	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
T	NULL
lymphoma	NULL
cells	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
preceded	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
serine-727	NULL
phosphorylation	NULL
coordinates	NULL
well	NULL
with	NULL
the	NULL
recent	NULL
reports	NULL
that	NULL
ERK-MAPK-induced	NULL
phosphorylation	NULL
of	NULL
serine-727	NULL
reduced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
6	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Because	NULL
STAT3	NULL
is	NULL
constitutively	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
,	NULL
and	NULL
because	NULL
the	NULL
turnover	NULL
of	NULL
phosphotyrosine	NULL
STAT3	NULL
is	NULL
slow	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
ref	NULL
.	NULL

22	NULL
;	NULL
MN	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
the	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
might	NULL
not	NULL
be	NULL
caused	NULL
by	NULL
an	NULL
inhibition	NULL
of	NULL
de	NULL
novo	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
by	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Instead	NULL
,	NULL
PP2A	NULL
inhibitors	NULL
might	NULL
induce	NULL
tyrosine	NULL
dephosphorylation	NULL
of	NULL
STAT3	NULL
via	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
(	NULL
PTPs	NULL
)	NULL
.	NULL

Others	NULL
have	NULL
hypothesized	NULL
that	NULL
serine	NULL
phosphorylation	NULL
triggers	NULL
a	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
via	NULL
an	NULL
unidentified	NULL
negative	NULL
feedback	NULL
mechanism	NULL
involving	NULL
PTPs	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
present	NULL
finding	NULL
that	NULL
CA-induced	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
always	NULL
preceded	NULL
a	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
compatible	NULL
with	NULL
this	NULL
hypothesis	NULL
.	NULL

Because	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
decreased	NULL
binding	NULL
of	NULL
STAT3	NULL
«	NULL
to	NULL
the	NULL
GASd	NULL
and	NULL
GASp	NULL
probes	NULL
was	NULL
caused	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3a	NULL
«	NULL
.	NULL

It	NULL
was	NULL
a	NULL
repeated	NULL
observation	NULL
that	NULL
STAT3a	NULL
«	NULL
binding	NULL
to	NULL
the	NULL
hSIE	NULL
and	NULL
ICAM-1	NULL
probes	NULL
was	NULL
profoundly	NULL
inhibited	NULL
by	NULL
PP2A	NULL
inhibitors	NULL
,	NULL
whereas	NULL
the	NULL
binding	NULL
of	NULL
STAT3B	NULL
was	NULL
not	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
two	NULL
isoforms	NULL
of	NULL
STAT3	NULL
are	NULL
regulated	NULL
differently	NULL
by	NULL
PP2A	NULL
.	NULL

Because	NULL
STAT3	NULL
«	NULL
enhances	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
ICAM-1	NULL
gene	NULL
,	NULL
whereas	NULL
STAT3B	NULL
inhibits	NULL
it	NULL
(	NULL
25	NULL
)	NULL
,	NULL
it	NULL
makes	NULL
sense	NULL
that	NULL
the	NULL
two	NULL
STAT3	NULL
isoforms	NULL
are	NULL
regulated	NULL
differently	NULL
.	NULL

The	NULL
physiological	NULL
role	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
is	NULL
still	NULL
controversial	NULL
.	NULL

As	NULL
mentioned	NULL
earlier	NULL
,	NULL
serine	NULL
phosphorylation	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
and	NULL
several	NULL
kinases	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
these	NULL
complex	NULL
regulatory	NULL
events	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
10-14	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
PP2A	NULL
,	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
also	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
serine/threonine	NULL
phosphorylation	NULL
and	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
at	NULL
present	NULL
how	NULL
inhibitors	NULL
of	NULL
PP2A	NULL
induce	NULL
serine	NULL
and	NULL
threonine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

Inhibitors	NULL
of	NULL
PP2A	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
ERK/MAPKs	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
ERK/MAPKs	NULL
are	NULL
responsible	NULL
for	NULL
cytokine-induced	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
several	NULL
models	NULL
(	NULL
6	NULL
,	NULL
10-12	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
PD98059	NULL
almost	NULL
completely	NULL
blocked	NULL
CA-and	NULL
OA-induced	NULL
activation	NULL
of	NULL
p42/44	NULL
ERK	NULL
without	NULL
affecting	NULL
the	NULL
induction	NULL
of	NULL
phosphoserine	NULL
STAT3	NULL
strongly	NULL
suggest	NULL
that	NULL
STAT	NULL
serine	NULL
phosphorylation	NULL
was	NULL
not	NULL
mediated	NULL
via	NULL
the	NULL
MEK-MAP	NULL
(	NULL
ERK	NULL
)	NULL
pathway	NULL
.	NULL

Instead	NULL
,	NULL
our	NULL
findings	NULL
show	NULL
that	NULL
inhibitors	NULL
of	NULL
PP2A	NULL
trigger	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
via	NULL
a	NULL
staurosporine	NULL
A-sensitive	NULL
pathway	NULL
.	NULL

PP2A	NULL
may	NULL
function	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
an	NULL
as-yet-unidentified	NULL
,	NULL
staurosporine-sensitive	NULL
,	NULL
STAT3	NULL
serine/threonine	NULL
kinase	NULL
.	NULL

According	NULL
to	NULL
this	NULL
hypothesis	NULL
,	NULL
inhibition	NULL
of	NULL
PP2A	NULL
triggers	NULL
an	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
phosphorylates	NULL
STAT3	NULL
.	NULL

Because	NULL
PP2A	NULL
(	NULL
but	NULL
not	NULL
PP1	NULL
)	NULL
recently	NULL
was	NULL
shown	NULL
to	NULL
dephosphorylate	NULL
serine-phosphorylated	NULL
STAT3	NULL
in	NULL
vitro	NULL
(	NULL
34	NULL
)	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
serine-phosphorylated	NULL
STAT3	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
PP2A	NULL
in	NULL
vivo	NULL
and	NULL
that	NULL
the	NULL
level	NULL
of	NULL
STAT3	NULL
serine	NULL
phosphorylation	NULL
is	NULL
balanced	NULL
between	NULL
serine	NULL
phosphorylation	NULL
by	NULL
a	NULL
constitutively	NULL
,	NULL
activated	NULL
,	NULL
staurosporine-sensitive	NULL
kinase	NULL
and	NULL
dephosphorylation	NULL
by	NULL
PP2A	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
our	NULL
model	NULL
,	NULL
serine-phosphorylated	NULL
STAT3	NULL
is	NULL
almost	NULL
exclusively	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
not	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Confocal	NULL
laser	NULL
scanning	NULL
microscopy	NULL
indicated	NULL
that	NULL
CA	NULL
treatment	NULL
induced	NULL
a	NULL
rapid	NULL
change	NULL
in	NULL
subcellular	NULL
distribution	NULL
of	NULL
STAT3	NULL
.	NULL

Because	NULL
the	NULL
redistribution	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
coincided	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
serine/threonine	NULL
phosphorylation	NULL
(	NULL
and	NULL
not	NULL
with	NULL
the	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
)	NULL
we	NULL
hypothesize	NULL
that	NULL
PP2A	NULL
inhibition	NULL
by	NULL
CA	NULL
and	NULL
OK	NULL
induces	NULL
serine	NULL
phosphorylation	NULL
of	NULL
nuclear	NULL
STAT3	NULL
proteins	NULL
,	NULL
which	NULL
subsequently	NULL
are	NULL
exported	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
present	NULL
study	NULL
provides	NULL
evidence	NULL
that	NULL
PP2A	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT3	NULL
phosphorylation	NULL
,	NULL
subcellular	NULL
distribution	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
CD4*	NULL
T	NULL
cell	NULL
and	NULL
T	NULL
lymphoma	NULL
cells	NULL
Because	NULL
cytokines	NULL
such	NULL
as	NULL
IL-2	NULL
induce	NULL
a	NULL
transient	NULL
drop	NULL
in	NULL
PP2A	NULL
activity	NULL
,	NULL
which	NULL
coincides	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
serine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
(	NULL
38	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
PP2A	NULL
also	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine-induced	NULL
STAT3	NULL
signaling	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Craig	NULL
W.	NULL
Reynolds	NULL
(	NULL
Biological	NULL
Response	NULL
Modifiers	NULL
Program	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
rIL-2	NULL
and	NULL
Gitte	NULL
Kglander	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
The	NULL
Danish	NULL
Research	NULL
Councils	NULL
,	NULL
Danish	NULL
Biotech-	NULL
Biochemistry	NULL
:	NULL
Woetmann	NULL
et	NULL
al	NULL
.	NULL

nological	NULL
Center	NULL
for	NULL
Cellular	NULL
Communication	NULL
,	NULL
Danish	NULL
Allergy	NULL
Research	NULL
Center	NULL
,	NULL
Novo	NULL
Nordic	NULL
Foundation	NULL
,	NULL
Becketts	NULL
Fond	NULL
,	NULL
Danish	NULL
Medical	NULL
Associations	NULL
Research	NULL
Foundation	NULL
,	NULL
The	NULL
Danish	NULL
Cancer	NULL
Research	NULL
Foundation	NULL
(	NULL
Dansk	NULL
Kraeftsforsknings	NULL
Fond	NULL
)	NULL
,	NULL
The	NULL
Danish	NULL
Cancer	NULL
Society	NULL
(	NULL
Kraeftens	NULL
Bekzempelse	NULL
)	NULL
,	NULL
Kobmand	NULL
i	NULL
Odense	NULL
Johann	NULL
og	NULL
Hanne	NULL
Weimann	NULL
f.	NULL
Seedorff	NULL
's	NULL
Legat	NULL
,	NULL
The	NULL
Carlsberg	NULL
Foundation	NULL
,	NULL
and	NULL
University	NULL
of	NULL
Copenhagen	NULL
.	NULL

1	NULL
.	NULL

2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

Leaman	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Leung	NULL
,	NULL
S.	NULL
,	NULL
Li	NULL
,	NULL
X	NULL
.	NULL

&	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1578-1588	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

&	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
,	NULL
293-322	NULL
.	NULL

Liu	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Gaffen	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Goldsmith	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
271-278	NULL
.	NULL

Mufson	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

11	NULL
,	NULL
37-44	NULL
.	NULL

Wen	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1997	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25	NULL
,	NULL
2062-2067	NULL
.	NULL

Chung	NULL
,	NULL
J.	NULL
,	NULL
Uchida	NULL
,	NULL
E.	NULL
,	NULL
Grammer	NULL
,	NULL
T.	NULL
C.	NULL
&	NULL
Blenis	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
6508-6516	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Zhong	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
241-250	NULL
.	NULL

Eilers	NULL
,	NULL
A.	NULL
,	NULL
Georgellis	NULL
,	NULL
D.	NULL
,	NULL
Klose	NULL
,	NULL
B.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
&	NULL
Decker	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3579-3586	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
Blenis	NULL
,	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
H.-C.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
&	NULL
Chen-Kiang	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1990-1994	NULL
.	NULL

Sengupta	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Talbot	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Scherle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Ivashkiv	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
11107-11112	NULL
.	NULL

Jain	NULL
,	NULL
N.	NULL
,	NULL
Zhang	NULL
,	NULL
T.	NULL
,	NULL
Fong	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Lim	NULL
,	NULL
C.	NULL
P.	NULL
&	NULL
Cao	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Oncogene	NULL
17	NULL
,	NULL
3157-3167	NULL
.	NULL

Ng	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Cantrell	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
24542-24549	NULL
.	NULL

Zhu	NULL
,	NULL
X.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Xu	NULL
,	NULL
L.	NULL
Z	NULL
.	NULL

&	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
6618-6623	NULL
.	NULL

Boulton	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
Stahl	NULL
,	NULL
N.	NULL
&	NULL
Yancopoulos	NULL
,	NULL
G.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
6915-6919	NULL
.	NULL

Gonzalez	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Raden	NULL
,	NULL
D.	NULL
L.	NULL
&	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
22159-22163	NULL
.	NULL

Ceresa	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Horvath	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Pessin	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Endocrinology	NULL
138	NULL
,	NULL
4131-4137	NULL
.	NULL

David	NULL
,	NULL
M.	NULL
,	NULL
Petricoin	NULL
III	NULL
,	NULL
E.	NULL
,	NULL
Benjamin	NULL
,	NULL
C.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
Weber	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

&	NULL
Larner	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
1721-1723	NULL
.	NULL

Beadling	NULL
,	NULL
C.	NULL
,	NULL
Ng	NULL
,	NULL
J.	NULL
,	NULL
Babbage	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Cantrell	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1902-1913	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
_	NULL
10625	NULL
Hayakawa	NULL
,	NULL
F.	NULL
,	NULL
Towatari	NULL
,	NULL
M.	NULL
,	NULL
Iida	NULL
,	NULL
H.	NULL
,	NULL
Wakao	NULL
,	NULL
H.	NULL
,	NULL
Kiyoi	NULL
,	NULL
H.	NULL
,	NULL
Naoe	NULL
,	NULL
T.	NULL
&	NULL
Saito	NULL
,	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

101	NULL
,	NULL
521-528	NULL
.	NULL

Mumby	NULL
,	NULL
M.	NULL
C.	NULL
&	NULL
Walter	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Physiol	NULL
.	NULL

Rev	NULL
.	NULL

73	NULL
,	NULL
673-699	NULL
.	NULL

Nielsen	NULL
,	NULL
M.	NULL
,	NULL
Odum	NULL
,	NULL
N.	NULL
,	NULL
Bendtzen	NULL
,	NULL
K.	NULL
,	NULL
Ryder	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Jakobsen	NULL
,	NULL
K.	NULL
B	NULL
.	NULL

&	NULL
Svejgaard	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Exp	NULL
.	NULL

Clin	NULL
.	NULL

Immunogenet	NULL
.	NULL

11	NULL
,	NULL
23-32	NULL
.	NULL

Nielsen	NULL
,	NULL
M.	NULL
,	NULL
Kaltoft	NULL
,	NULL
K.	NULL
,	NULL
Nordahl	NULL
,	NULL
M.	NULL
,	NULL
Ropke	NULL
,	NULL
C.	NULL
,	NULL
Geisler	NULL
,	NULL
C.	NULL
,	NULL
Mustelin	NULL
,	NULL
T.	NULL
,	NULL
Dobson	NULL
,	NULL
P.	NULL
,	NULL
Svejgaard	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Odum	NULL
,	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
,	NULL
6764-6769	NULL
.	NULL

Kaltoft	NULL
,	NULL
K.	NULL
,	NULL
Bisballe	NULL
,	NULL
S.	NULL
,	NULL
Dyrberg	NULL
,	NULL
T.	NULL
,	NULL
Boel	NULL
,	NULL
E.	NULL
,	NULL
Rasmussen	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

&	NULL
Thestrup-Pedersen	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
In	NULL
Vitro	NULL
Cell	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

28A	NULL
,	NULL
161-167	NULL
.	NULL

Lécine	NULL
,	NULL
P.	NULL
,	NULL
Algarté	NULL
,	NULL
M.	NULL
,	NULL
Rameil	NULL
,	NULL
P.	NULL
,	NULL
Beadling	NULL
,	NULL
C.	NULL
,	NULL
Bucher	NULL
,	NULL
P.	NULL
,	NULL
Nabholz	NULL
,	NULL
M.	NULL
&	NULL
Imbert	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
6829-6840	NULL
.	NULL

Caldenhoven	NULL
,	NULL
E.	NULL
,	NULL
van	NULL
Dijk	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Solair	NULL
,	NULL
R.	NULL
,	NULL
Armstrong	NULL
,	NULL
J.	NULL
,	NULL
Raaijmarkers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
,	NULL
Lammers	NULL
,	NULL
J.-W.	NULL
J.	NULL
,	NULL
Koenderman	NULL
,	NULL
L.	NULL
&	NULL
de	NULL
Groot	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
13221-13227	NULL
.	NULL

Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Hayes	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Hoban	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

&	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
4477-4484	NULL
.	NULL

Nielsen	NULL
,	NULL
M.	NULL
,	NULL
Nordahl	NULL
,	NULL
M.	NULL
,	NULL
Svejgaard	NULL
,	NULL
A	NULL
.	NULL

&	NULL
dum	NULL
,	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Cytokine	NULL
10	NULL
,	NULL
735-738	NULL
.	NULL

Nielsen	NULL
,	NULL
M.	NULL
,	NULL
Keestel	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Eriksen	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Woetmann	NULL
,	NULL
A.	NULL
,	NULL
Stokkedal	NULL
,	NULL
T.	NULL
,	NULL
Kaltoft	NULL
,	NULL
K.	NULL
,	NULL
Geisler	NULL
,	NULL
C.	NULL
,	NULL
Ropke	NULL
,	NULL
C.	NULL
&	NULL
Odum	NULL
,	NULL
N.	NULL
(	NULL
1999	NULL
)	NULL
Leukemia	NULL
13	NULL
,	NULL
735-738	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Farmer	NULL
,	NULL
J.	NULL
D.	NULL
Jr.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Friedman	NULL
,	NULL
J.	NULL
,	NULL
Weissman	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
66	NULL
,	NULL
807-815	NULL
.	NULL

Walsh	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
Zydowsky	NULL
,	NULL
L.	NULL
D.	NULL
&	NULL
McKeon	NULL
,	NULL
F.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
13115-13118	NULL
.	NULL

Honkanan	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Codispoti	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Tse	NULL
,	NULL
K.	NULL
&	NULL
Boynton	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Toxicon	NULL
32	NULL
,	NULL
339-350	NULL
.	NULL

Bialojan	NULL
,	NULL
C.	NULL
&	NULL
Takao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

256	NULL
,	NULL
283-290	NULL
.	NULL

Li	NULL
,	NULL
Y.-M.	NULL
&	NULL
Casida	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
11867-11870	NULL
.	NULL

Liitticken	NULL
,	NULL
C.	NULL
,	NULL
Coffer	NULL
,	NULL
P.	NULL
,	NULL
Yuan	NULL
,	NULL
J.	NULL
,	NULL
Schwartz	NULL
,	NULL
C.	NULL
,	NULL
Caldehoven	NULL
,	NULL
E.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Kruijer	NULL
,	NULL
W.	NULL
,	NULL
Heinrich	NULL
,	NULL
P.	NULL
C.	NULL
&	NULL
Horn	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

360	NULL
,	NULL
137-143	NULL
.	NULL

Harris	NULL
,	NULL
W.	NULL
,	NULL
Hill	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Lewis	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Nixon	NULL
,	NULL
J.	NULL
S.	NULL
&	NULL
Wilkinson	NULL
,	NULL
S.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Drugs	NULL
Fut	NULL
.	NULL

18	NULL
,	NULL
727-735	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
Nowak	NULL
,	NULL
I.	NULL
,	NULL
Vonderheid	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Rook	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Kadin	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Shaw	NULL
,	NULL
L.	NULL
M.	NULL
&	NULL
Wasik	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
9148-9153	NULL
.	NULL

Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1997	NULL
)	NULL
Science	NULL
277	NULL
,	NULL
1630-1635	NULL
.	NULL

Brockdorff	NULL
,	NULL
J.	NULL
,	NULL
Nielsen	NULL
,	NULL
M.	NULL
,	NULL
Dobson	NULL
,	NULL
P.	NULL
,	NULL
Geisler	NULL
,	NULL
C.	NULL
,	NULL
Ropke	NULL
,	NULL
C.	NULL
,	NULL
Svejgaard	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Odum	NULL
,	NULL
N.	NULL
(	NULL
1997	NULL
)	NULL
Tissue	NULL
Antigens	NULL
49	NULL
,	NULL
228-235	NULL
.	NULL

